Cargando…
Chemotherapy in Neuroendocrine Tumors
SIMPLE SUMMARY: Cytotoxic chemotherapy is a standard therapy for patients with poorly differentiated neuroendocrine carcinomas, however, its role in patients with well differentiated neuroendocrine tumors is less defined. In this review, we describe the data supporting many of the chemotherapy regim...
Autores principales: | Das, Satya, Al-Toubah, Taymeyah, Strosberg, Jonathan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8507720/ https://www.ncbi.nlm.nih.gov/pubmed/34638356 http://dx.doi.org/10.3390/cancers13194872 |
Ejemplares similares
-
Efficacy of Capecitabine and Temozolomide in Small Bowel (Midgut) Neuroendocrine Tumors
por: Al-Toubah, Taymeyah, et al.
Publicado: (2022) -
What is the role of checkpoint inhibitors in neuroendocrine neoplasms?
por: Al-Toubah, Taymeyah, et al.
Publicado: (2020) -
Targeted radionuclide therapy in endocrine-related cancers: advances in the last decade
por: Al-Toubah, Taymeyah, et al.
Publicado: (2023) -
HORMONET: a phase II trial of tamoxifen for estrogen/progesterone receptor-positive neuroendocrine tumors
por: Barros, Milton J., et al.
Publicado: (2023) -
Efficacy of ipilimumab and nivolumab in patients with high-grade neuroendocrine neoplasms
por: Al-Toubah, T., et al.
Publicado: (2021)